<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.28932.005</object-id><label>Table 2.</label><caption><title>Demographics of patients after stratified random sampling into training and testing sets.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th valign="top">Training <break/>(n&#160;=&#160;135)</th><th valign="top">Testing <break/>(n&#160;=&#160;44)</th><th valign="top">p-value</th></tr><tr><th valign="top">Age, years, median (SD) *</th><th valign="top">56 (8.1)</th><th valign="top">56 (8.3)</th><th valign="top">1.0</th></tr></thead><tbody><tr><td valign="top">CA-125, units/ml, median (SD) <sup>*</sup></td><td valign="top">126.5 (1193.5)</td><td valign="top">105.6 (577.8)</td><td valign="top">0.91</td></tr><tr><td valign="top">Pathology, n (%)<sup>&#8224;</sup></td><td valign="top"/><td valign="top"/><td valign="top">1.0</td></tr><tr><td valign="top">&#8195;Control</td><td valign="top">11 (8.1)</td><td valign="top">4 (9.1)</td><td valign="top"/></tr><tr><td valign="top">&#8195;Benign lesions</td><td valign="top">34 (25.2)</td><td valign="top">11 (25.0)</td><td valign="top"/></tr><tr><td valign="top">&#8195;Borderline tumors</td><td valign="top">16 (11.9)</td><td valign="top">5 (11.4)</td><td valign="top"/></tr><tr><td valign="top">&#8195;Stage I/II invasive cancers</td><td valign="top">41 (30.4)</td><td valign="top">12 (27.3)</td><td valign="top"/></tr><tr><td valign="top">&#8195;Stage III/IV invasive cancers</td><td valign="top">33 (24.4)</td><td valign="top">12 (27.3)</td><td valign="top"/></tr></tbody></table><table-wrap-foot><fn><p>*student&#8217;s t-test</p><p><sup>&#8224;</sup>chi-square test</p></fn></table-wrap-foot></table-wrap>